The risk of COVID-19 in patients with psoriasis: A retrospective cohort study
Published: 25 July 2022| Version 1 | DOI: 10.17632/68fht87h68.1
Supplement I. CONSORT diagram for the cohorts of patients with psoriasis. PsA, psoriatic arthritis Supplement II. Multivariable Logistic Regression Assessing Factors (ICD-10) Associated with COVID-19 Infection aMultivariable logistic regression models were constructed with COVID-19 as the dependent variable, psoriasis as the independent variable, and the following covariates: age (linear), sex (male vs. female), race (Caucasian vs. non-caucasian), congestive heart failure, chronic obstructive pulmonary disease, type-2 diabetes mellitus, and obesity. Adjusted odds ratios were computed for patients with psoriasis and general population controls. P-value less than 0.05 was considered significant. Bold values indicate significant results.
Epidemiology of Psoriasis, COVID-19